Company intelligence / Profile preview

Cyban

Melbourne, Victoria, Australiacyban.com.au ↗

Ownership: Private
Employees: ~13
Development stage: Other

Overview

Cyban has developed a proprietary non-invasive brain pulse oximeter ("BPOx") designed to continuously monitor cerebral oxygenation in patients with acute traumatic brain injuries. The technology aims to enable earlier detection of secondary brain injury due to hypoxia, potentially reducing mortality and long-term disability. Clinical studies have demonstrated efficacy for detecting changes in microvascular oxygen levels and blood flow. The company received significant government investment to support commercialization efforts and regulatory submissions.

Therapeutic areas: Neurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Breakthrough VictoriaSignificant Early Venture CapitalInterValley Venturespartnerships with hospitals/clinical sites for trials

Beyond the preview

Go deeper on Cyban.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyban.

Explore the full profile